Stay updated on ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial involving ASP1517 in peritoneal dialysis chronic kidney disease patients with anemia, while retaining the study's collaborators and revision history.SummaryDifference26%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.